ATEDIO

This brand name is authorized in Japan.

Active ingredients

The drug ATEDIO contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Cilnidipine UNII `97T5AZ1JIP` - CILNIDIPINE
	Read more about Cilnidipine
`2`	Valsartan UNII `80M03YXJ7I` - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT₁-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
JP	医薬品医療機器総合機構	2149120F1027

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.